Dow Geoffrey S's Form 4 filing
60 Degrees Pharmaceuticals, Inc. (SXTP) · filed Dec 12, 2025
- Accession no.
- 0001213900-25-120948
- Filed
- Dec 12, 2025
- Trade date
- Dec 10-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $12.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dow Geoffrey SCIK 0001977231 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Common Stock | PPurchaseAcquired | +9,350 | $0.95 | +$8,882.5 | 46,335 | Direct | |
| Dec 11, 2025 | Common Stock | PPurchaseAcquired | +3,613 | $0.92 | +$3,323.96 | 49,948 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.